How Glutathione Dissolves Hydrogels

Hydrogels are widely used in biomedical applications, from drug delivery to tissue engineering, thanks to their water-rich, flexible structure. However, controlling their breakdown is just as important as their formation—especially in targeted therapies where timing matters. One effective method to dissolve certain hydrogels relies on a clever chemical process: the thiol–disulfide exchange reaction.

Among the agents capable of triggering this reaction, glutathione (GSH) has emerged as a key player. Used at concentrations of 1%, 3%, and 5% weight per volume in phosphate-buffered saline (PBS) at a neutral pH of 7.4, GSH acts as a thiolate donor. This means it provides reactive thiol groups that actively attack and break the disulfide bonds holding the hydrogel network together.

As GSH cleaves these bonds, it doesn't remain unchanged—it becomes oxidized in the process, converting into its dimeric form, GSSG. This redox activity mirrors natural cellular processes, making GSH not only effective but also biocompatible. This is particularly valuable in physiological environments where controlled degradation is essential.

Because glutathione is naturally present in cells—especially at higher levels inside the cytoplasm—hydrogels designed to dissolve via GSH are ideal for intracellular drug delivery. They remain stable outside cells but rapidly break down once internalized, releasing their payload precisely where needed.

The use of GSH as a dissolution agent, first highlighted in studies around February 2017, underscores how mimicking biological mechanisms can lead to smarter, responsive biomaterials. By leveraging simple yet powerful chemistry, researchers continue to refine how hydrogels behave in the body—improving safety, precision, and therapeutic outcomes.

See also

In-depth articles

Related topics